Protection of Experimental Cobalt Cardiomyopathy in the Rat by Selenium Pretreatment

  • Jian-Qi Cui
  • Guang-Lu Xu
Conference paper


Clinical evidence has implicated cobalt (Co) in the etiology of a primary myocardial disease occurring among certain heavy beer drinkers when Co was added to the beer (McDermott et al. 1966; Bonenfant et al. 1967; Morin et al. 1967; Kesteloot et al. 1968; Alexander 1972). Investigators have reported in experimental animals Co-induced myocardial damage similar to the pathologic manifestations of the beer drinker’s heart disease (Sandusky et al. 1981). It has been reported that Co acts to accelerate the in vivo formation of lipid peroxides (LPO) in the blood of rabbits and causes a decrease in superoxide dismutase (SOD) activity, but fails to alter glutathione peroxidase (GSH-Px) in erythrocytes (Kuno et al. 1980; Morita et al. 1982). Selenium (Se)-vitamin E protection against acute Co cardiotoxicity has been observed in swine (Van Vleet et al. 1977).


Sodium Selenite Vertical Column Glutamic Oxaloacetic Transaminase Keshan Disease Beer Drinker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alexander CS (1972) Cobalt beer cardiomyopathy: a clinical and pathologic study of 28 cases. Am J Med 53: 395–417PubMedCrossRefGoogle Scholar
  2. Bonenfant JL, Miller G, Roy PE (1967) Quebec beer-drinkers’ cardiomyopathy: pathologic studies. Can Med Assoc J 97: 910–916PubMedGoogle Scholar
  3. Kesteloot H, Roelandt J, Williams J, Claes JH, Joossens JV (1968) An inquiry about the role of cobalt in the heart disease of chronic beer drinkers. Circulation 37: 854–864PubMedGoogle Scholar
  4. Kuno Y, Tochihara N, Koike S (1980) The effects of cobalt chloride on the formation of blood lipid peroxide related to glutathione peroxidase in the erythrocytes of rabbits. Jpn J Hyg 35: 665–669CrossRefGoogle Scholar
  5. McDermott PH, Delaney RL, Egan JD, Sullivan JF (1966) Myocardosis and cardiac failure in men. JAMA 198: 253–256PubMedCrossRefGoogle Scholar
  6. Morin Y, Daniel P (1967) Quebec beer drinkers’ cardiomyopathy: etiological consideration. Can Med Assoc J 97: 926–929PubMedGoogle Scholar
  7. Morita H, Kuno Y, Koike S (1982) The effects of cobalt on superoxide dismutase activity, methemoglobin formation and lipid peroxide in rabbit. Jpn J Hyg 37: 597–600CrossRefGoogle Scholar
  8. Sandusky GE, Henk WG, Roberts ED (1981) Histochemistry and ultrastructure of the heart in experimental cobalt cardiomyopathy in the dog. Toxicol Appl Pharmacol 61: 89–95PubMedCrossRefGoogle Scholar
  9. Van Vleet JF, Rebar AH, Ferrans VJ (1977) Acute cobalt and isoproterenol cardiotoxicity in swine: protection by selenium-vitamin E supplementation and potentiation by stress-susceptible phenotype. Am J Vet Res 38: 991–1002Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • Jian-Qi Cui
    • 1
  • Guang-Lu Xu
    • 1
  1. 1.Research Laboratory of Keshan DiseaseXi’an Medical UniversityXi’an, ShaanxiThe People’s Republic of China

Personalised recommendations